Chemclin Diagnostics Co., Ltd. (688468.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.96B |
| Enterprise Value | 3.04B |
| P/E Ratio | 69.45 |
| PEG Ratio | -1.04 |
| Price/Sales Ratio | 7.39 |
| Price/Book Ratio | 1.89 |
| Enterprise/Revenue | 7.74 |
| Enterprise/EBITDA | 33.69 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.12 |
| Operating Margin | 0.13 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.03 |
Income Statement
| Revenue | 330.38M |
| Revenue/Share | 0.72 |
| Gross Profit | 198.38M |
| EBITDA | 112.73M |
| Net Income | 43.91M |
| Diluted EPS | 0.11 |
Balance Sheet
| Total Cash | 388.7M |
| Total Cash/Share | 0.87 |
| Total Debt | 232.62M |
| Total Debt/Equity | 0.16 |
| Current Ratio | 4.77 |
| Book Value Per Share | 3.17 |
Price History
| 52-Week Change | -31.74 |
| 52-Week High | 9.12 |
| 52-Week Low | 5.5 |
| Moving Average 50 Days | 6.09 |
| Moving Average 200 Days | 7.26 |
Statistics
| Average Volume | 3.46M |
| Shares Outstanding | 401.11M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 1.37 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
